The Wall Street Journal: Eli Lilly COVID-19 antibody drug shipments paused over variant concerns


U.S. health officials have paused the distribution of two Eli Lilly & Co. Covid-19 monoclonal antibody treatments because of data showing they aren’t effective against virus variants that are becoming increasingly common across the country.

: Virgin Galactic’s stock rockets to a record gain after FAA clears passenger flights into space

Previous article

Market Extra: Is the reflation trade over? What stock-market investors need to watch

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News